Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Marsh

TitleAdjunct Clinical Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Medicine, College of Medicine
DivisionCardiovascular Medicine
Address3S 08 Shorey
4301 W Markham St.
Mail Slot # 832
Little Rock AR 72205
Phone501-686-7045
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    James D. Marsh, M.D. is the Nolan Professor and chairman of the Department of Internal Medicine in the College of Medicine at the University of Arkansas for Medical Sciences (UAMS). He directs the overall clinical, research and teaching activities of nine medical divisions with over one hundred faculty members. Dr. Marsh attended Harvard College in Cambridge, Mass., majoring in chemistry and graduating magna cum laude. He attended Harvard Medical School and received his internal medicine training at Brigham and Women’s Hospital in Boston, subsequently completing clinical and research training in cardiovascular diseases, also at Brigham and Women’s Hospital.In 1980 he joined the faculty at Harvard Medical School, where he rose through the ranks to the position of associate professor. He served as director of the cardiology fellowship program at Brigham and Women’s Hospital for 13 years. In 1993, he moved to Wayne State University in Detroit as a professor of medicine. There he was appointed director of the Division of Cardiology and associate chairman of the Department of Internal Medicine.


    Collapse Research Funds 
    Collapse research activities
    0755762Z     (MARSH, JAMES)Jul 1, 2007 - Jun 30, 2009
    American Heart Association
    Gene based calcium channel modulation
    Role: Principal Investigator

    Research Agreement     (YACCOBY, SHMUEL)May 31, 2006 - May 31, 2009
    ZymoGenetics, Inc
    Effect of TACI-lg and BAFFR-lg on primary myeloma growth in SCID-hu mice
    Role: Principal Investigator

    R01HL073097     (PALADE, PHILIP T.)Dec 20, 2003 - Nov 30, 2008
    NIH/NHLBI
    Cav1.2 Transcript Regulation in Heart and Smooth Muscle
    Role: Co-Investigator

    R01HL054086     (MARSH, JAMES D)Mar 12, 1996 - Feb 29, 2000
    NIH/NHLBI
    CALCIUM REGULATING PROTEINS IN CARDIAC MYOCYTES
    Role: Principal Investigator

    K08HL000691     (MARSH, JAMES D)Dec 1, 1985 - Jun 30, 1988
    NIH/NHLBI
    CARDIAC BETA RECEPTOR AND CA CHANNEL REGULATION
    Role: Principal Investigator

    R01HL035781     (MARSH, JAMES D)Sep 30, 1985 - Sep 29, 1995
    NIH/NHLBI
    REGULATION OF THE CARDIAC CALCIUM CHANNEL
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Mathur P, Kadavath S, Marsh JD, Mehta JL. Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs. Eur Heart J. 2020 Dec 21; 41(48):4577-4579. PMID: 31723974.
      View in: PubMed
    2. Culp WC, Onteddu SS, Brown A, Nalleballe K, Sharma R, Skinner RD, Witt T, Roberson PK, Marsh JD. Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial. J Vasc Interv Radiol. 2019 Aug; 30(8):1244-1250.e1. PMID: 31349978.
      View in: PubMed
    3. Salata RA, Geraci MW, Rockey DC, Blanchard M, Brown NJ, Cardinal LJ, Garcia M, Madaio MP, Marsh JD, Todd RF. U.S. Physician-Scientist Workforce in the 21st Century: Recommendations to Attract and Sustain the Pipeline. Acad Med. 2018 04; 93(4):565-573. PMID: 28991849.
      View in: PubMed
    4. Blanchard M, Burton MC, Geraci MW, Madaio MP, Marsh JD, Proweller A, Rockey DC, Salata RA, Tan W, Williams CS, Zaidi M, Todd RF. Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine. Am J Med. 2018 05; 131(5):578-584. PMID: 29410155.
      View in: PubMed
    5. Marsh JD, Chod R. Recruiting Faculty Leaders at U.S. Medical Schools: A Process Without Improvement? Acad Med. 2017 11; 92(11):1564-1568. PMID: 28471777.
      View in: PubMed
    6. Lowery CL, Elliott C, Cooper A, Hadden C, Sonon RN, Azadi P, Williams DK, Marsh JD, Woulfe DS, Kilic F. Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets. J Am Heart Assoc. 2017 May 18; 6(5). PMID: 28522678.
      View in: PubMed
    7. Marsh JD, Todd RF. Training and sustaining physician scientists: what is success? Am J Med. 2015 Apr; 128(4):431-6. PMID: 25554377.
      View in: PubMed
    8. Hayes K, Deshmukh A, Pant S, Culp B, Marsh J, Paydak H. Flecainide associated torsade de pointes: A potential case of reverse use dependence. J Res Med Sci. 2013 Dec; 18(12):1108-9. PMID: 24523805.
      View in: PubMed
    9. Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD. Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department. Vasc Health Risk Manag. 2013; 9:187-93. PMID: 23662064.
      View in: PubMed
    10. Xiong WW, Karam PY, Marsh JD, Varma N, Verdino RJ, Paydak H. Innovative P-wave detection for discrimination between ventricular and supraventricular tachycardia in single-chamber ICDs: is the P-wave invisible during tachycardia? Europace. 2013 Jun; 15(6):827-34. PMID: 23512155.
      View in: PubMed
    11. Yang JD, Acharya K, Evans M, Marsh JD, Beland S. Beriberi disease: is it still present in the United States? Am J Med. 2012 Oct; 125(10):e5. PMID: 22800868.
      View in: PubMed
    12. Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD. Evolving role of platelet function testing in coronary artery interventions. Vasc Health Risk Manag. 2012; 8:65-75. PMID: 22371653.
      View in: PubMed
    13. Marsh JD, Keyrouz SG. Stroke prevention and treatment. J Am Coll Cardiol. 2010 Aug 24; 56(9):683-91. PMID: 20723798.
      View in: PubMed
    14. Marsh JD, Keyrouz SG. Stroke prevention and treatment: state of the art. J Am Col Cardiol. 2010.
    15. Brott TG et al, Marsh JD (collaborator; DSMB chair). Stenting versus endarterectomy for treatment of carotid-artery stenosis (CREST). N Engl J Med. 2010; 363(1):11-23.
    16. Marsh JD. Turning cardiac excitation into cell contraction: the importance of sex differences. . 2010 Jul; 299(1):H16-7. PMID: 20495144.
      View in: PubMed
    17. Mehta JL, Bursac Z, Mehta P, Bansal D, Fink L, Marsh J, Sukhija R, Sachdeva R. Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals. Am J Cardiol. 2010 Apr 01; 105(7):1019-23. PMID: 20346324.
      View in: PubMed
    18. Lees KR et al, Marsh JD (NINDS Data and Safety Monitoring Committee). Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010; 375(9727):1695-703.
    19. Telemaque S, Marsh JD. Modification of cardiovascular ion channels by gene therapy. Expert Rev Cardiovasc Ther. 2009 Aug; 7(8):939-53. PMID: 19673672.
      View in: PubMed
    20. Telemaque S, Marsh JD. Modification of ion channels by gene therapy. Expert Review of Cardiovascular Therapy. 2009; 7(8):939-53.
    21. Nassief A, Marsh JD. Statin therapy for stroke prevention. Stroke. 2008 Mar; 39(3):1042-8. PMID: 18258828.
      View in: PubMed
    22. Télémaque S, Sonkusare S, Grain T, Rhee SW, Stimers JR, Rusch NJ, Marsh JD. Design of mutant beta2 subunits as decoy molecules to reduce the expression of functional Ca2+ channels in cardiac cells. J Pharmacol Exp Ther. 2008 Apr; 325(1):37-46. PMID: 18184831.
      View in: PubMed
    23. Marsh JD, Telemaque S, Rhee SW, Stimers JR, Rusch NJ. Delivery of ion channel genes to treat cardiovascular diseases. Trans Am Clin Climatol Assoc. 2008; 119:171-82; discussion 182-3. PMID: 18596857.
      View in: PubMed
    24. Ramappa P, Thatai D, Coplin W, Gellman S, Carhuapoma JR, Quah R, Atkinson B, Marsh JD. Cardiac troponin-I: a predictor of prognosis in subarachnoid hemorrhage. Neurocrit Care. 2008; 8(3):398-403. PMID: 18087680.
      View in: PubMed
    25. Telemaque S, Sonkusare S, Grain T, Rhee SW, Stimers JR, Rusch NJ, Marsh J. Design of mutant beta subunits as decoy molecules to reduce the expression of functional Ca 2+ channels in cardiac cells. J Pharmacol Exp Ther. 2008; 325(1):37-46.
    26. Nassief A, Marsh J. Statin therapy for stroke prevention (Review). Stroke. 2008; 39(3):1042-8.
    27. Marsh J. (and by invitation: Telemaque S, Rhee SW, Stimers JR, Rusch) Delivery of ion channel genes to treat cardiovascular diseases (Review). Transactions of the American Clinical and Climatological Association. 2008; 119:171-183.
    28. Milstein ML, McFarland TP, Marsh JD, Cala SE. Inefficient glycosylation leads to high steady-state levels of actively degrading cardiac triadin-1. J Biol Chem. 2008 Jan 25; 283(4):1929-35. PMID: 18025088.
      View in: PubMed
    29. Sonkusare S, Fraer M, Marsh JD, Rusch NJ. Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel. Mol Interv. 2006 Dec; 6(6):304-10. PMID: 17200457.
      View in: PubMed
    30. Rajamani K, Sunbulli M, Jacobs BS, Berlow E, Marsh JD, Kronenberg MW, McLaughlin P, Vouyouka A, Levine SR, Lai Z, Chaturvedi S. Detection of carotid stenosis in African Americans with ischemic heart disease. J Vasc Surg. 2006 Jun; 43(6):1162-5. PMID: 16765232.
      View in: PubMed
    31. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch NJ. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol. 2006 Mar; 44(3):131-42. PMID: 16427812.
      View in: PubMed
    32. Marsh J. Progress in stroke prevention and treatment (Review). Cardiology Rounds: Brigham and Women's Hospital. 2006; 10(2).
    33. Chen X, Zhang X, Kubo H, Harris DM, Mills GD, Moyer J, Berretta R, Potts ST, Marsh JD, Houser SR. Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res. 2005 Nov 11; 97(10):1009-17. PMID: 16210547.
      View in: PubMed
    34. Golden KL, Marsh JD, Jiang Y, Moulden J. Acute actions of testosterone on contractile function of isolated rat ventricular myocytes. Eur J Endocrinol. 2005 Mar; 152(3):479-83. PMID: 15757866.
      View in: PubMed
    35. Li H, Télémaque S, Miller RE, Marsh JD. High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes. 2005 Feb; 54(2):540-5. PMID: 15677513.
      View in: PubMed
    36. Fan QI, Vanderpool KM, Chung HS, Marsh JD. The L-type calcium channel alpha 1C subunit gene undergoes extensive, uncoordinated alternative splicing. Mol Cell Biochem. 2005 Jan; 269(1-2):153-63. PMID: 15786728.
      View in: PubMed
    37. Kher N, Marsh JD. Pathobiology of atherosclerosis--a brief review. Semin Thromb Hemost. 2004 Dec; 30(6):665-72. PMID: 15630673.
      View in: PubMed
    38. Ram ML, Kiarash A, Marsh JD, Cala SE. Phosphorylation and dephosphorylation of calsequestrin on CK2-sensitive sites in heart. Mol Cell Biochem. 2004 Nov; 266(1-2):209-17. PMID: 15646044.
      View in: PubMed
    39. Golden KL, Marsh JD, Jiang Y, Moulden J. Gonadectomy alters myosin heavy chain composition in isolated cardiac myocytes. Endocrine. 2004 Jul; 24(2):137-40. PMID: 15347839.
      View in: PubMed
    40. Golden KL, Marsh JD, Jiang Y, Brown T, Moulden J. Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. Am J Physiol Endocrinol Metab. 2003 Sep; 285(3):E449-53. PMID: 12684218.
      View in: PubMed
    41. Vouyouka AG, Salib SS, Cala S, Marsh JD, Basson MD. Chronic high pressure potentiates the antiproliferative effect and abolishes contractile phenotypic changes caused by endothelial cells in cocultured smooth muscle cells. J Surg Res. 2003 Apr; 110(2):344-51. PMID: 12788664.
      View in: PubMed
    42. Fan QI, Vanderpool KM, O'Connor J, Marsh JD. Decoy calcium channel beta subunits modulate contractile function in myocytes. Mol Cell Biochem. 2003 Jan; 242(1-2):3-10. PMID: 12619859.
      View in: PubMed
    43. Golden KL, Marsh JD, Jiang Y. Castration reduces mRNA levels for calcium regulatory proteins in rat heart. Endocrine. 2002 Dec; 19(3):339-44. PMID: 12624436.
      View in: PubMed
    44. Marsh JD. Early use of glycoprotein IIb/IIIa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes. Am J Health Syst Pharm. 2002 Nov 01; 59(21 Suppl 7):S15-26. PMID: 12434711.
      View in: PubMed
    45. Fan QI, Vanderpool K, Marsh JD. A 27 bp cis-acting sequence is essential for L-type calcium channel alpha(1C) subunit expression in vascular smooth muscle cells. Biochim Biophys Acta. 2002 Sep 27; 1577(3):401-11. PMID: 12359330.
      View in: PubMed
    46. Kuo TH, Zhu L, Golden K, Marsh JD, Bhattacharya SK, Liu BF. Altered Ca2+ homeostasis and impaired mitochondrial function in cardiomyopathy. Mol Cell Biochem. 2002 Sep; 238(1-2):119-27. PMID: 12349899.
      View in: PubMed
    47. Golden KL, Ren J, Dean A, Marsh JD. Norepinephrine regulates the in vivo expression of the L-type calcium channel. Mol Cell Biochem. 2002 Jul; 236(1-2):107-14. PMID: 12190108.
      View in: PubMed
    48. Sotolongo CM, Marsh J. Cardiovascular Medicine for Students. Cardiovascular Pharmacology. 2002.
    49. Racine E, Marsh J. State of the Heart. Common Drugs for Heart Patients. 2000.
    50. Marsh J. State of the Heart. Dissolving blood clots during heart attacks. 2000.
    51. Choudhury L, Marsh JD. Myocardial infarction in young patients (Review). Am J Med. 1999; 107(3):254 - 261.
    52. Vander Heide RS, Marsh JD. Through the looking glass: a positive inotropic drug and ischemic preconditioning. Circulation. 1997; 95(8):1989 - 1991.
    53. Ritchie RH, Marsh J. Cardiology Looseleaf. Cardiovascular Adrenergic and Muscarinic Cholinergic Receptors. 1997.
    54. El-Zaru MR, Liu L, Hines RN, Marsh JD. Isolation and characterization of the 5' flanking sequence of the rat L-type calcium channel a1C subunit gene. Circ. 1997; 96(8):1-54.
    55. Davidoff AJ, Walsh M, Marsh J, Sowers JR. Calcium Antagonists in Clinical Medicine. Myocardial and Vascular Smooth Muscle Calcium Metabolism in Diabetes. 1997.
    56. Marsh JD, Bacon LD, Fadly AM. Effect of serotype 2 and 3 Marek's disease vaccines on the development of avian leukosis virus-induced pre-neoplastic bursal follicles. Avian Dis. 1995; 39(4):743 - 751.
    57. Leonen MF, Marsh J. The Guide to Cardiology. Cardiovascular Problems in Patients with Primarily Noncardiac Disease. 1995.
    58. Gruver EJ, Toupin D, Smith TW, Marsh JD. Acadesine improves tolerance to ischemic injury in rat cardiac myocytes. J Mol Cell Cardiol. 1994; 26(9):1187 - 1195.
    59. Nishida M, Borzak S, Kraemer B, Navas JP, Kelly RA, Smith TW, Marsh JD. Role of cation gradients in hypercontracture of myocytes during simulated ischemia and reperfusion. Am J Physiol. 1993; 264(6 Pt 2):H1896 - H1906.
    60. Marsh J. Diastolic Relaxation of the Heart. Adrenergic Signal Transduction in Congestive Heart Failure: Effects on Diastole. 1993.
    61. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD, Gwathmey JK. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol. 1992; 263(5 Pt 2):H1576 - H1586.
    62. Borzak S, Reers M, Arruda J, Sharma VK, Sheu SS, Smith TW, Marsh JD. Na+ efflux mechanisms in ventricular myocytes: measurement of [Na+]i with Na(+)-binding benzofuran isophthalate. Am J Physiol. 1992; 263(3 Pt 2):H866 - H874.
    63. Sun SC, Appleyard R, Masetti P, Byrne JG, Laurence RG, Marsh JD, Cohn LH. Improved recovery of heart transplants by combined use of oxygen-derived free radical scavengers and energy enhancement. J Thorac Cardiovasc Surg. 1992; 104(3):830 - 837.
    64. Allen PD, Schmidt TA, Marsh JD, Kjeldsen K. Na,K-ATPase expression in normal and failing human left ventricle (Review). Basic Res Cardiol. 1992; 87 Suppl 1:87 - 94.
    65. Landzberg J, Marsh J. Cardiovascular Review and Reports. Cardiovascular Problems in Patients with Primarily Noncardiac Disease. 1992.
    66. DiSesa VJ, Masetti P, Diaco M, Schoen FJ, Marsh JD, Cohn LH. The mechanism of heart failure caused by cardiac allograft rejection. J Thorac Cardiovasc Surg. 1991; 101(3):446 - 449.
    67. Liang MH, Stern S, Fortin PR, Louie DC, Marsh JD, Mudge GH, Murphy G. Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: a new syndrome presenting with facial swelling and pericardial tamponade. Arthritis Rheum. 1991; 34(2):228 - 233.
    68. Marsh JD, Smith TS. Calcium overload and ischemic myocardial injury (Review). Circulation. 1991; 83(2):709 - 711.
    69. Marsh JD, Smith TW. Calcium channels and cardiomyopathy (Review). J Mol Cell Cardiol. 1991; 23(2):105 - 107.
    70. Landzberg J, Marsh J. The Guide to Cardiology. Cardiovascular Problems in Patients with Primarily Noncardiac Disease. 1991.
    71. Antman EM, Marsh J. Electrophysiology and Pharmacology of the Heart. Class IV Antiarrhythmic Drugs. 1991.
    72. Navas JP, Anderson W, Marsh JD. Hypothermia increases calcium content of hypoxic myocytes. Am J Physiol. 1990; 259(2 Pt 2):H333 - H339.
    73. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med. 1990; 31(4):464 - 472.
    74. Marsh JD. Myocyte response to stimulation of receptors and ion channels (Review). Toxicol Pathol. 1990; 18(4 Pt 1):454 - 463.
    75. Marsh J, Borzak S, Esumi K, Navas JP. Recent Advance in Calcium Channels and Calcium Antagonists. Calcium Homeostasis in Cardiac Myocyte Models of Ischemic Injury. 1990.
    76. Colucci WS, Ribeiro JP, Rocco MB, Quigg RJ, Creager MA, Marsh JD, Gauthier DF, Hartley LH. Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization. Circulation. 1989; 80(2):314 - 323.
    77. Denniss AR, Colucci WS, Allen PD, Marsh JD. Distribution and function of human ventricular beta adrenergic receptors in congestive heart failure. J Mol Cell Cardiol. 1989; 21(7):651 - 660.
    78. Barnett JV, Haigh LS, Marsh JD, Galper JB. Effects of low density lipoproteins and mevinolin on sympathetic responsiveness in cultured chick atrial cells. Regulation of beta-adrenergic receptors and alpha s. J Biol Chem. 1989; 264(18):10779 - 10786.
    79. Denniss AR, Marsh JD, Quigg RJ, Gordon JB, Colucci WS. Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. Circulation. 1989; 79(5):1028 - 1034.
    80. Marsh JD, Sweeney KA. Beta-adrenergic receptor regulation during hypoxia in intact cultured heart cells. Am J Physiol. 1989; 256(1 Pt 2):H275 - H281.
    81. Marsh JD, Allen PD. Developmental regulation of cardiac calcium channels and contractile sensitivity to [Ca]o. Am J Physiol. 1989; 256(1 Pt 2):H179 - H185.
    82. Murphy JG, Smith TW, Marsh JD. Mechanisms of reoxygenation-induced calcium overload in cultured chick embryo heart cells. Am J Physiol. 1988; 254(6 Pt 2):H1133 - H1141.
    83. Colucci WS, Denniss AR, Leatherman GF, Quigg RJ, Ludmer PL, Marsh JD, Gauthier DF. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. J Clin Invest. 1988; 81(4):1103 - 1110.
    84. Marsh JD, Margolis TI, Kim D. Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol. 1988; 254(1 Pt 2):H20 - H27.
    85. Marsh J. Calcium flux measurements in cultured heart cells. 1988.
    86. Murphy JG, Marsh JD, Smith TW. The role of calcium in ischemic myocardial injury (Review). Circulation. 1987; 75(6 Pt 2):V15 - V24.
    87. Murphy JG, Smith TW, Marsh JD. Calcium flux measurements during hypoxia in cultured heart cells. J Mol Cell Cardiol. 1987; 19(3):271 - 279.
    88. Olson EM, Kim D, Smith TW, Marsh JD. Mechanism of the positive inotropic effect of milrinone in cultured embryonic chick ventricular cells. J Mol Cell Cardiol. 1987; 19(1):95 - 104.
    89. Pennington JE, Kemmerich B, Kazanjian PH, Marsh JD, Boerth LW. Verapamil impairs human neutrophil chemotaxis by a non-calcium-mediated mechanism. J Lab Clin Med. 1986; 108(1):44 - 52.
    90. Laurent S, Marsh JD, Smith TW. Enkephalins increase cyclic adenosine monophosphate content, calcium uptake, and contractile state in cultured chick embryo heart cells. J Clin Invest. 1986; 77(5):1436 - 1440.
    91. Marsh J, Smith TW. Digitalis Glycosides. Epidemiology and General Considerations of Digitalis Toxicity. 1986.
    92. Marsh J, Smith TW. Digitalis Glycosides. Clinical Use of Cardiac Glycosides in Congestive Heart Failure. 1986.
    93. Marsh J, Smith TW. Digitalis Glycosides. Clincal Manifestations of Digitalis Toxicity. 1986.
    94. Blatt C, Marsh J, Smith TW. Digitalis Glycosides. The Role of Neural Factors in Digitalis Intoxication. 1986.
    95. Marsh J, Smith TW. Digitalis Glycosides. Miscellaneous Uses of Cardiac Glycosides. 1986.
    96. Marsh JD, Smith TW. Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects (Review). Pharmacotherapy. 1984; 4(4):170 - 180.
    97. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part III. Prog Cardiovasc Dis. 1984; 27(1):21 - 56.
    98. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part II (Review). Prog Cardiovasc Dis. 1984; 26(6):495 - 540.
    99. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part I. Prog Cardiovasc Dis. 1984; 26(5):413 - 458.
    100. Marsh JD. The cultured heart cell: a useful model for physiological and biochemical investigation (Review). Int J Cardiol. 1983; 3(4):465 - 468.
    101. Marsh J. A Guide to Cardiology. Cardiovascular Problems in Patients with Primarily Noncardiac Disease. 1983.
    102. Marsh JD, Nesto R, Glynn MA, Smith TW. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure. J Cardiovasc Pharmacol. 1982; 4(6):949 - 954.
    103. Smith TW, Barry WH, Marsh JD, Lorell B. Hypoxia, calcium fluxes, and inotropic state: studies in cultured heart cells (Review). Am Heart J. 1982; 103(4 Pt 2):716 - 723.
    104. Barry WH, Pober J, Marsh JD, Frankel SR, Smith TW. Effects of graded hypoxia on contraction of cultured chick embryo ventricular cells. Am J Physiol. 1980; 239(5):H651 - H657.
    105. Vatner SF, Marsh JD, Swain JA. Effects of morphine on coronary and left ventricular dynamics in conscious dogs. J Clin Invest. 1975; 55(2):207 - 217.
    106. Marsh JD. Early use of glycoprotein IIb/IIIa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes (Review). Am J Health Syst Pharm. 59(21 Suppl 7):S15 - S26.
    107. Telemaque-Potts S, John SK, Grain T, Potts JT, Marsh J. Expression of beta 2 subunit mutants alters localization of L-type calcium channels in rat adult cardiomyocytes.
    108. Marsh J. Does an early invasive strategy for ACS save lives?. Evidence-based cardiovascular medicine. 8:278-279.
    109. Liu L, Fan QI, El-Zaru M, Vanderpool K, Hines RN, Marsh J. Identification of regulatory sequences in the L-type calcium channels a1c subunit gene that confer adrenergic and steroid responsiveness.
    110. El-Zaru, Marsh J. Regulation of DHP receptor expression in rat heart by elements in the 5' flanking sequence.
    111. Fan QI, Vanderpool K, Chung H-S, Marsh J. Alternative splicing of the alpha 1-c gene for the L-type calcium channel in the cardiovascular system.
    112. Matthews S, Deutsch DD, Iyer G, Hora N, Pati B, Grunberger G, Marsh J. Alpha2-HS glycoprotein kinetics after acute myocardial infraction quantified by a modified ELISA. Clinica Chimica Acta. 319(27-34).
    113. Telemaque-Potts S, Brown L, Grain T, Fan QI, Marsh J. Nkx2.5 is involved in regulation of L-type calcium channel gene expression in vascular smooth muscle cells.
    114. Sonkusare S, Fraer M, Marsh JD, Rusch NJ. Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel (Review). Mol Interv. 6(6):304 - 310.
    115. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch NJ. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications (Review). Vascul Pharmacol. 44(3):131 - 142.
    116. Marsh J. Ethics and Policy in Scientific Publication. Repetitive Publications.
    117. Sonkusare, S, Stimers, JR, Grain, T, Marsh J. Expression of Beta-2 subunit mutants alters calcium currents in HL-1 cells.
    118. Marsh JD, Antman EM. T-type calcium channel blockade in the management of chronic ischemic heart disease. Cardiovasc Drugs Ther. 14(5):459 - 461.
    Marsh's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _